Singapore markets closed

Amyris, Inc. (AMRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.78-0.16 (-2.31%)
At close: 1:00PM EST
6.74 -0.04 (-0.59%)
After hours: 04:40PM EST

Amyris, Inc.

5885 Hollis Street
Suite 100
EmeryVille, CA 94608
United States
510 450 0761
http://www.amyris.com

Sector(s)Basic Materials
IndustrySpecialty Chemicals
Full-time employees595

Key executives

NameTitlePayExercisedYear born
Mr. John G. MeloPres, CEO & Director1.34MN/A1966
Mr. Hermanus KieftenbeldCFO & Chief Admin. Officer817.84kN/A1966
Mr. Eduardo AlvarezChief Operating Officer959.76kN/A1964
Ms. Nicole KelseyGen. Counsel & Sec.541.53kN/A1967
Mr. Anthony HughesChief Accounting OfficerN/AN/A1965
Mr. Peter DeNardoSr. Director of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Christine OforiChief People OfficerN/AN/AN/A
Mr. Charles KraftSr. VP of Global Manufacturing & Process Devel.N/AN/AN/A
Ms. Caroline HadfieldPres of AprinnovaN/AN/AN/A
Mr. Jim IacoponiSr. VP of Nutrition IngredientsN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

Corporate governance

Amyris, Inc.’s ISS governance QualityScore as of 26 September 2021 is 10. The pillar scores are Audit: 10; Board: 7; Shareholder rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.